cyclopropanecarboxylic acid has been researched along with bd 1047 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aricò, G; Marrazzo, A; Parenti, C; Prezzavento, O; Ronsisvalle, G; Ronsisvalle, S; Scoto, GM; Vittorio, F | 1 |
1 other study(ies) available for cyclopropanecarboxylic acid and bd 1047
Article | Year |
---|---|
A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Cyclopropanes; Dose-Response Relationship, Drug; Ethylenediamines; Ligands; Male; Molecular Structure; Pain Measurement; Pentazocine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, sigma | 2008 |